Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Philip Spandorfer

Pediatrics Atlanta, GA Medical Doctor

NPI 1972566883 CMS profile 89484

1001 Johnson Ferry Rd Ne, Atlanta, GA 30342

Open in the dashboard

General payments

$3,735

154 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Philip Spandorfer of Atlanta, GA is reported in the CMS Open Payments database as having received $3,735 across 154 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $813 36
2024 General $1,141 32
2023 General $818 38
2022 General $440 23
2021 General $343 14
2020 General $53 3
2019 General $127 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philip Spandorfer
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Philip Spandorfer were reported at $813. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Philip Spandorfer Pediatrics median Middle half National median
2019 $127 $86 $31–$183 $163
2020 $53 $49 $22–$110 $114
2021 $343 $68 $27–$158 $132
2022 $440 $77 $30–$173 $149
2023 $818 $88 $33–$190 $160
2024 $1,141 $94 $34–$206 $164
2025 $813 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supernus Pharmaceuticals, Inc. $1,577 53 payments
  2. Corium, Inc. $539 27 payments
  3. Sanofi Pasteur Inc. $225 5 payments
  4. Ironshore Pharmaceuticals Inc. $192 8 payments
  5. Cranial Technologies, Inc $189 7 payments
  6. Neos Therapeutics, LP $173 9 payments
  7. Pfizer Inc. $158 8 payments
  8. Merck Sharp & Dohme Corporation $122 8 payments
  9. Collegium Pharmaceutical, Inc. $101 5 payments
  10. Tris Pharma Inc $59 3 payments
  11. Other $398 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,703 152 payments
  2. Education $33 2 payments
Products named General payments · program years 2019–2025
  1. Qelbree Viloxazine Hydrochloride $808 14 payments
  2. QELBREE Psychology $769 39 payments
  3. Azstarys $539 27 payments
  4. BEYFORTUS $202 4 payments
  5. JORNAY PM Central Nervous System Stimulant $192 8 payments
  6. Doc Band $189 7 payments
  7. Adzenys XR-ODT $125 7 payments
  8. GARDASIL 9 $110 7 payments
  9. Jornay PM Adhd $101 5 payments
  10. VAXELIS $99 4 payments
  11. Other $1,209 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record